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Purpose: To determine whether taurine exerts a protective effect on retinal pigment epithelium (RPE) cells exposed to a
cytotoxic agent, cytochrome C (cyC), shown previously to induce apoptosis and produce cell death in electrically coupled
neighboring cells.
Methods: Monolayer cultures of confluent human RPE (ARPE-19) cells, which express gap-junctional proteins, were
incubated in culture medium with or without taurine. After scrape loading cyC into the cells, we assayed these cells for
caspase 3 activity and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining to determine the
spread of apoptosis.
Results: We found that cyC, too large a molecule to traverse gap junctional channels, produced apoptosis in cells injured
by the scrape as well as those distant from the site of the scrape, presumably by the intercellular transmission of a toxic
agent through the gap junctions that couple these cells. Incubation in taurine, or the gap-junction blocker, octanol, before
application of cyC, reduced significantly the fraction of cells undergoing apoptosis. Voltage clamp recordings from
electrically coupled Xenopus oocytes transfected with Cx43 showed that junctional communication was unaffected by
taurine.
Conclusions: Our results indicate that taurine can serve to suppress cell death in RPE cells independent of any effect on
gap junctions. We have considered various avenues by which taurine can exert its protective effect, but the precise
mechanism involved under these experimental conditions has yet to be identified.
The present study was prompted by a growing number of
reports advocating the use of taurine and related compounds
as therapeutic agents for a wide range of disorders that induce
apoptosis in tissues throughout the body [1-3]. For example,
it  has  been  shown  that  taurine  serves  as  a  free  radical
scavenger and an antagonist to oxidative stress in protecting
heart, lung, and liver cells from cell death [4-7], and it has
proven  useful  as  an  anticonvulsant  in  reducing  epileptic
seizures [8]. In addition, there is good evidence that taurine,
one  of  the  major  constituents  of  the  mammalian  central
nervous system, is essential for normal retinal development
[9,10].  The  concentration  of  taurine  in  the  distal  layers,
including  photoreceptors  and  retinal  pigment  epithelium
(RPE), of the vertebrate retina is estimated to be 60–80 mM
[11-13]. Although taurine’s precise function has often been
conjectural,  numerous  studies  have  shown  that  a  taurine-
deficient diet, or the inhibition of taurine transport, causes
photoreceptor  loss  and  RPE  abnormalities  in  a  variety  of
animal species including primates [9,14-17].
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Interestingly,  despite  the  high  oxygen  consumption
required to meet the energy demand of cells of the distal retina,
more proximal retinal layers exhibit a greater susceptibility to
metabolic or hypoxic/ischemic insult [18]. Indeed, it appears
likely that photoreceptors and RPE cells are rendered resistant
to  metabolic  insufficiencies  by  an  endogenous  agent  that
serves either to prevent apoptosis or to suppress the spread of
cell death across the layers of cells that constitute the RPE and
the photoreceptors, each of which is linked to its neighbors by
gap  junctions  [19-21].  In  the  present  study  we  sought  to
determine whether taurine can exert a protective effect on RPE
cells using the human RPE (ARPE-19) cell line as a model
system.
To address these issues we modified a scrape-loading
technique used earlier to study the spread of apoptosis through
gap-junctional channels [22,23]. The method involves the
introduction of cytochrome C (cyC) to trigger downstream
caspase activity in a limited population of cultured cells, i.e.,
those opened to the extracellular milieu by the scrape, and to
then  assay  by  immunocytochemistry  and  terminal
deoxynucleotidyl  transferase  dUTP  nick  end  labeling
(TUNEL) staining the spread of apoptosis to neighboring cells
through the gap junctions with which they are coupled. The
procedure enabled us to examine the effects of taurine on the
induction  and  spread  of  apoptosis  in  an  ARPE-19
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1940immortalized cell line derived from human RPE [24]. Because
of the possibility that taurine inhibits gap junction intercellular
communication  (GJIC),  we  determined  whether  taurine
affects GJIC between Xenopus oocytes electrically coupled
through heterologous expression of the RPE gap junctional
protein, Cx43.
METHODS
Reagents: The sources from which we obtained primary and
secondary antibodies for immunocytochemistry are indicated
in the text; serum-free media (Neurobasal) was from Gibco
(Invitrogen,  Carlsbad,  CA);  all  other  chemicals  were
analytical grade or better, and purchased from Sigma-Aldrich,
St. Louis, MO.
Cell line: Cultures of ARPE-19 cells, provided by Dr. Beatrice
Yue (Department of Ophthalmology, University of Illinois
College of Medicine, Chicago, IL) were seeded at a density
of roughly 1 × 104 cells/cm2 in polystyrene dishes with a glass
bottom (Becton Dickinson, Franklin Lakes, NJ). The medium
was changed every 3–4 days, and the cells were grown to
confluency  in  a  normal  growth  medium,  consisting  of
Dulbecco’s  modified  Eagle’s  medium  (DMEM)
supplemented with 10% fetal bovine serum and 1% penicillin
and 1% streptomycin (1% PS). Cells were kept in a 37 °C
incubator under a humidified 5% CO2 : 95% air atmosphere,
and were dissociated twice weekly by mild treatment with
0.25%  trypsin  and  0.02%  ethylenediaminetetraacetic  acid
(EDTA) and subcultured in the growth medium.
Western  blot  analysis:  ARPE-19  cells  were  grown  to
confluence on 25 cm2 Primaria tissue culture flasks (Becton
Dickinson). Cells were removed by scraping and solubilized
with SDS sample buffer, which contained 2% SDS, 10%
glycerol, 200 mM HEPES at pH 6.8, 1 mM EDTA, 0.1%
bromphenol blue, and 5% 2-mercaptoethanol. The buffer was
supplemented  with  a  protease  inhibitor  cocktail  (Roche
Diagnostics,  Indianapolis,  IN).  Samples  were  resolved  by
Figure 1. Connexin expression in ARPE-19 cells. A: Immunocytochemistry: an antibody to connexin 43 was revealed with Alexa 488-tagged
secondary antibody, and the antibody to connexin 46 was visualized by fluorescent microscopy with a cy3-tagged secondary antibody. Punctate
labeling characteristic of connexin plaques was seen both in the region of cell apposition (arrows) and at the cell surface. In the left panel,
scale bar in the Differential interference contrast (DIC; upper) image represents 40 μm, while scale bar in the phase (lower) image represents
20 μm. B: Western blotting: Aliquot of whole cell ARPE-19 lysate (20 µg total protein) were resolved by SDS–PAGE on a 6% Laemmli gel
and transferred to PVDF membrane. Anti-Cx43 antibody labeled several bands corresponding to phosphorylated species of Cx43 (major bands
identified by arrows at 69 and 52) and a minor band corresponding to nonphosphorylated Cx43 (arrow at 43). Numbers and lines to the right
indicate the positions of molecular weight markers.
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1941SDS–PAGE on 6% Laemmli gels (20 µg total protein per
lane), and transferred to PVDF membranes. Membranes were
blocked  with  Super  Block  (Pierce  Biotechnology,  Inc.,
Rockford, IL) and exposed to rabbit anticonnexin 43 antibody
(Zymed Laboratories Inc., San Francisco, CA; catalog number
71–0700) at 1:500 dilution in high sodium TBS buffer that
contained 500 mM NaCl and 25 mM Tris buffer, pH 7.5.
Cross-reacting bands were visualized using antirabbit alkaline
phosphatase  secondary  antibody  (Vector  Laboratories,
Burlingame,  CA)  and  chemiluminescent  detection  using
Immunobilon  Western  AP  Substrate  (Millipore,  Bedford,
MA). Signals were captured with the Image Station 440 CF
New England Nuclear (NEN, Boston, MA) and analyzed with
Kodak 1D Image Analysis Software.
Connexin expression: The cellular localization of Cx43 and
Cx46, gap junctional proteins expressed by ARPE-19 cells
[20,25,26] was examined by immunocytochemistry (Figure
1). Connexin expression and GJIC are prerequisites for the
intercellular spread of cell death by toxic agents generated
during apoptosis in our experimental protocol [22,23]. Cells
were plated on sterile 35 mm plastic dishes, grown to near
confluence,  washed  with  PBS  (17  mM  KH2PO4,  5  mM
Na2HPO4,  150  mM  NaCl),  and  fixed  either  with  4%
paraformaldehyde in PBS, or in buffered methanol, which was
composed  of  90%  methanol,  10  mM  HEPES,  0.1  mM
MgCl2, and 0.1 mM EGTA, chilled to −20 °C. Similar findings
were obtained with both fixatives and will not be considered
further  in  the  Results  section.  The  cells  were  then
permeabilized  in  0.1%  Triton-X-100  for  10  min  at  room
temperature  then  blocked  for  2  h  at  37  °C  in  a  solution
containing either 3% fetal calf serum or 10% goat serum in
PBS. They were incubated overnight at 4 °C in a polyclonal
rabbit anticonnexin 43 antibody against a synthetic peptide
corresponding to a segment of the third cytoplasmic domain
of  rat  connexin43  (Zymed  Laboratories  Inc.).  Antibody
binding was visualized by fluorescent microscopy using goat
antirabbit Alexa 488 secondary antibody (Molecular Probes,
Inc., Eugene, OR) as well as with a sheep antirabbit FITC
secondary antibody (Jackson ImmunoResearch Laboratories,
West  Grove,  PA).  Cells  were  similarly  examined  for  the
expression of connexin 46, by incubating with a polyclonal
rabbit anticonnexin 46 antibody (a gift from Dr. Nalin Kumar,
Department of Ophthalmology, University of Illinois College
of  Medicine,  Chicago,  IL),  and  a  donkey  antirabbit  cy3
secondary  antibody  (Jackson  ImmunoResearch
Laboratories). Differential interference contrast (DIC), phase
contrast, and fluorescence images were collected using either
a  Zeiss  Axiovert  100  M  microscope  (Zeiss,  Oberkochen,
Germany) or an Olympus Fluoview 300 confocal microscope.
Intercellular communication: To determine whether the RPE
cells  expressing  connexins  Cx43  and  Cx46  formed
communicating junctions with their neighbors, we gently cut
a region of the monolayer with the point of a scalpel blade.
The cells were then bathed for 5 min in 1 ml PBS solutions
supplemented with 100 μl of a 0.05% solution of Lucifer
yellow (LY; Sigma) and 100 μl of 5 mg/ml solution of dextran
rhodamine B, 10000 MW, neutral (DR; Molecular Probes
Inc.). Thereafter, the LY-DR solution was exchanged for the
normal growth medium, and the cells were incubated at 37 °C
for 1 h. LY is able to traverse the aqueous pores of gap
junctions, which typically allow the passage of ions and small
molecules ≤1 kDa [27-29], whereas the DR complex can only
enter the cells that were injured by the scrape. The cells were
fixed  briefly  (approximately  15  min)  with  4%
paraformaldehyde,  washed  once  with  PBS,  mounted  with
Vectashield  (Vector  Laboratories,),  and  examined  by
fluorescent microscopy (Figure 2).
Scrape loading cytochrome C and apoptotic assays: Cells
grown to confluency in 35-mm plastic dishes were incubated
overnight in DMEM supplemented with 10% FBS and 1% PS,
Figure 2. Dye spread in electrically coupled cells. Gap junctions
mediate the spread of Lucifer yellow (LY), indicating that junctional
permeability  and  the  system  of  intercellular  communication  are
intact. Arrowheads in all panels show the location of the small injury
(scrape) produced by the tip of the scalpel blade. Fluorescent images
of cells incorporating both dextran rhodamine (DR) and LY show
that whereas the rhodamine complex did not spread from the site of
the scrape (middle panel), LY spread through the gap junctions that
coupled the cells (lower panel). Scale bar (upper panel) equals 50
μm.
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1942either with (test) or without (negative control) the addition of
20  mM  taurine.  Additionally,  cells  were  incubated  with
10  mM  octanol  (Sigma),  a  substance  known  to  block
intercellular  gap  junctional  communication.  We  did  not
attempt to determine whether the ARPE-19 cells have an
endogenous  supply  of  taurine,  but  there  is  evidence  that
despite numerous passages this cell line contains a taurine
transporter to promote the entry of extracellular taurine [30,
31]. After removing the growth medium, we immersed the
cells in a PBS solution containing 100 μl of 1 mM cyC, and a
gentle touch with the blade of a mechanical tissue chopper
produced the “scrape” into which cyC entered the damaged
cells.  In  this  connection,  it  is  important  to  note  that  cyC
(12.3 kDa) is neither membrane permeable nor can it traverse
the pores of gap-junctional channels. The cells were incubated
in the cyC solution at room temperature for 5 min after which
growth medium containing 20 mM taurine was added to the
cyC  solution  bathing  the  “test”  cells,  which  were  then
incubated in the mixture for 2 h at 37 °C. Cells exposed to
octanol were treated in the same manner as taurine-incubated
cells, and they were incubated at 37 °C for 2 h in growth
medium containing octanol after induction of apoptosis with
cyC. After repeated rinses in PBS to remove the cyC, the cells
were fixed in 4% paraformaldehyde overnight at 4 °C and
prepared for histochemical analysis. In examining the figures
depicting caspase 3 activation and TUNEL staining (Figure 3
and Figure 4), it is important to recognize that most of the cells
incorporating cyC immediately adjacent to the scrape had died
and do not appear in the figures, having been washed away in
the rinses used to remove the cyC.
Caspase 3 activity and TUNEL staining—Cysteine-
dependent  aspartate-directed  proteases  (caspases)  play  a
prominent role in apoptosis [32,33], and caspase 3 activity
provides a reliable reporter of cells undergoing apoptosis;
DNA  degradation  revealed  by  TUNEL  staining  is  also
considered  to  be  a  major  indicator  of  apoptosis.  The
procedures for these and related assays of apoptosis have been
described previously [22]. Briefly, immunocytochemistry for
the presence of caspase 3 activity was performed using a rabbit
polyclonal antibody against cleaved caspase 3 (Cell Signaling
Technology,  Beverly,  MA).  The  caspase  3  antibody  was
diluted 1:100; the secondary antibody was donkey antirabbit
cy3 (Jackson ImmunoResearch Laboratories).
In the TUNEL assay, partially degraded DNA is labeled
with  fluorescein-dUTP  by  using  terminal
deoxynucleotidyltransferase  (TdT)  to  introduce  the
nucleotide preferentially into 3′ strand breaks [34]. TUNEL
label,  a  nucleotide  mix  containing  fluorescein-dUTP  and
dNTP  was  obtained  from  Roche  Applied  Science
(Indianapolis, IN). After induction of apoptosis by cyC, the
cells were treated according to the manufacturer’s instructions
for TUNEL staining. The cells were washed three times with
PBS and fixed with 4% paraformaldehyde in PBS for 1 h at
room temperature. They were then rinsed with PBS, incubated
for  2  min  with  an  ice-cold  permeabilization  solution
containing 0.1% Triton X-100 in 0.1% sodium citrate, and
rinsed again with PBS. Next, 5 μl of TdT and 45 μl of TUNEL
label solution were mixed well and added to the cells, which
were  allowed  to  incubate  at  37  °C  for  1  h  in  a  closed
humidified chamber. After two rinses in PBS, the cells were
mounted in Vectashield and viewed under the fluorescent
microscope.
Image acquisition and processing—Cells examined for
dye transfer and immunocytochemistry were visualized with
a Zeiss Axiovert 100 M microscope (Zeiss) through either a
plan-Neofluar  20X/0.5  or  an  Achroplan  40X/0.6  phase
objective, and photographed with a SensiCam CCD camera
(resolution  1280x1024;  Cooke  Corp.,  Auburn  Hills,  MI).
Image processing was controlled by MetaMorph software
(Universal Imaging Corp., Westchester, PA). For each of the
assays indicated, we determined the number of cells staining
for a specific marker within a 9.6 × 105 µm2 field that included
the site of the scrape. Computing the ratio of stained cells to
the entire cell population within the field gave the percentage
values  indicated  by  the  histograms  shown  in  Figure  5.
Figure 3. Cell death revealed by caspase 3 activity. In the absence of
taurine or the gap-junctional channel blocker octanol, an antibody to
active caspase 3 shows that cell death induced by incubation with
cytochome C (cyC) was widespread, extending to cells beyond the
scrape (upper panels). In contrast, cell death in the presence of taurine
(middle panels) or octanol (lower panels) was limited primarily to
cells along the lines of the scrape. White lines indicate the position
and approximate extent of the scrape. Scale bars represent 50 μm.
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1943Statistical  analysis  was  performed  using  Student’s  t-test;
differences at p<0.05 were considered significant.
Oocyte  preparation  and  electrophysiological
recording—Plasmids containing the coding sequence of rat
Cx43 were generously provided by Drs. David Spray (Albert
Einstein College of Medicine, New York, NY) and Thomas
White (State University of New York, Stony Brook, NY). The
construct  was  linearized  with  a  restriction  endonuclease
(Xba1), and capped mRNA was transcribed in vitro with T7
RNA polymerase using the mMessage mMachine (Ambion
Inc.,  Austin,  TX)  according  to  the  manufacturer’s
instructions.  Ovarian  lobes  were  removed  under  surgical
anesthesia (0.1% MS222; tricaine, ethyl 4-aminobenzoate)
from gravid Xenopus laevis females purchased from Xenopus
I  (Dexter,  MI).  The  animals  were  housed  in  climate-
controlled,  light-cycled  rooms  at  the  UIC  Biological
Resources  Laboratory,  and  fed  standard  frog  chow.  All
experimental procedures adhered to the guidelines for the care
and use of laboratory animals formulated by the Association
for Research in Ophthalmology and Visual Sciences, and were
approved by the Animal Care Committee of the University of
Illinois  at  Chicago  College  of  Medicine.  The  lobes  were
incubated with constant agitation for 2 h in a calcium-free
modified  Barth’s  (MB)  solution  containing  2.5  mg/ml
collagenase. Defolliculated stage V-VI oocytes were selected
and repeatedly rinsed in MB solution that contained 88 mM
NaCl,  1  mM  KCl  (1),  2.4  mM  NaHCO3,15  mM  N-2-
hydroxyethylpiperazine-N’-2-ethanesulfonic acid (HEPES),
0.33 mM Ca (NO3)2, 0.41 mM CaCl2, and 0.82 mM MgSO4;
10  mg/liter  gentamycin  (Gibco/BRL)  was  added,  and  the
solution  titrated  with  NaOH  to  pH  7.4.  After  overnight
incubation in MB at 15 °C, oocytes were injected with 46 nl
of an aqueous solution containing 10 ng or 20 ng/cell Cx43
cRNA using a Nanoject Injector (Drummond Scientific Co.,
Broomall, PA); 10 ng of an antisense oligonucleotide was
added  to  the  solution  to  suppress  the  activity  of  the
endogenous connexin (Cx38) of Xenopus oocytes [35]. Cells
receiving the antisense oligo alone served as controls.
Oocytes were tested 48-72 h after cRNA injection for the
effects of taurine on gap junctional conductance. The cells
were manually stripped of the vitelline envelope in hypertonic
medium [36], mounted on Teflon platforms within a Lucite
chamber (volume=0.7 ml), and paired at their vegetal poles
for 48 h before electrophysiological analysis using a dual
amplifier and dual electrode voltage clamp technique [37].
Solutions were superfused at a rate of 12 ml/minute using a
multiport  gravity  feed  system  (MP6  manifold;  Warner
Instrument Corp., Hamden, CT), and fluid was withdrawn
through  a  suction  pipette;  solution  exchange  within  the
chamber was complete in <8 s. Taurine was added to the MB
solution in concentrations of 20–40 mM without substitution;
no dose-dependent differences were observed. Current and
voltage electrodes (R=1–2 MΩ) were filled with a solution
containing 3 M KCl, 10 mM EGTA, and 10 mM HEPES, pH
7.4, and connected to the input stages of two GeneClamp 500B
amplifiers (Axon Instruments, Foster City, CA).
Both cells of a pair were initially clamped at −40 mV
(zero  junctional  potential,  Vj)  and  alternating  pulses  of
±10 mV were imposed to one cell. Current delivered to the
cell clamped at −40 mV during the voltage pulse was equal in
magnitude to the junctional current (Ij) and was divided by the
voltage  to  yield  the  conductance.  The  voltage-gating
properties were determined as follows: Vj values of opposite
polarity were generated by hyperpolarizing or depolarizing
one cell in 10 mV steps (over a range of ±80 mV) while
clamping the second cell at −40 mV. Currents were measured
8 s after the onset of the voltage pulse, at which time they
typically  reached  steady-state  (Ijss),  and  the  macroscopic
conductance (Gjss) was calculated by dividing Ijss by Vj. Gjss
was then normalized to the values determined at ±10 mV, and
plotted against Vj. Data describing the relationship of Gjss as
a  function  of  Vj  were  fit  to  a  Boltzmann  relation  [38],
additionally explained in the legend of Figure 6. The average
conductance of oocyte pairs selected for analysis of voltage
sensitivity was 4.8±0.6 μS (mean±SEM [standard error of the
mean]).  The  experimental  protocols  were  controlled  by
pClamp 8 software through a Digidata 1322A acquisition
interface (Axon), and data analysis and graphical displays
Figure  4.  Apoptosis  visualized  by  TUNEL.  TUNEL  staining  of
ARPE-19 cells incubated in the presence of cytochrome C (cyC) with
(middle panels) or without (upper panels) exposure to taurine also
showed that significantly fewer cells were undergoing cyC-induced
apoptosis in the presence of taurine. Octanol had a similar effect to
taurine in blocking the spread of cell death induced by cyC (lower
panels). Scale bars represent 50 μm.
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1944were performed with software programs in Clampfit 8 (Axon)
and  Origin  6.0  (MicroCal  Inc.,  Northhampton,  MA).
Junctional conductance and current-voltage data show the
means and variance (SEM) based on a minimum of 4 sets of
recordings for each experimental condition.
RESULTS
Before examining the effects of taurine on the spread of cell
death in cultured RPE cells, it was necessary to satisfy two
requisite conditions: confirm the presence of connexins on
RPE  cells  and  show  that  the  connexins  form  patent
intercellular pathways in the two cell lines. With respect to
connexin expression on RPE cells, earlier studies indicated
the presence of Cx43 (the predominant form) and Cx46 on
RPE  cells  using  immunohistochemical  [20],  biochemical
[25],  and  microarray  analyses  [26],  and  the  functional
properties of these intercellular junctions have been studied
extensively [39-41]. The expression of Cx43 and Cx46 in the
cells  used  in  this  study  was  examined  with
immunocytochemical  and  immunoblotting  techniques.
Typical  results  are  shown  in  Figure  1.  ARPE-19  cells
exhibited  the  punctate  labeling  characteristic  of  connexin
plaques on each of the RPE cells in the field of the microscope.
Punctate  staining  along  the  margin  between  cells  was
especially clear with anti-Cx43, and Cx labeling at the cell
surface was also evident. In this respect the labeling is similar
to that seen on other non-neuronal cell types, e.g., astrocytes
[42]. Immunoblot analysis further confirmed Cx43 expression
on ARPE19 cells. As described previously, anti-Cx43 labeled
multiple bands representing different phosphorylation states
of the protein [25]. Prominent bands at approximately 69 kDa
and 52 kDa are near the sizes reported for major upper and
lower phosphorylated forms of Cx43; other minor bands were
also detected. The arrow at 43 kDa identifies the position of
a weak band at the size expected for the nonphosphorylated
form of Cx43. Phosphorylation is implicated in the regulation
of a variety of connexin processes, and the finding of multiple
phosphorylated  Cx43  species  in  ARPE19  cells  suggests
involvement of this connexin isoform in the formation of
functional gap junction channels.
The gap junctions formed in apposed cells are permeable
to  LY,  a  tracer  that  provides  an  index  of  junctional
permeability. As shown in the images in Figure 2, when a
small incision is produced in the monolayer of ARPE-19 cells
and then exposed to a solution containing LY and DR, cells
remote from the site of injury were filled with LY. In contrast,
the larger DR complex is confined to the site of the lesion.
These results demonstrate that connexins are expressed in the
cell line used for this study, and that the system of intercellular
communication is intact.
Figure 3 illustrates the effects of taurine on the spread of
cyC-induced apoptosis revealed by the antibody to cleaved
caspase 3. These images show that before introducing taurine
(upper panels), cell death spread to many cells remote from
the site of injury (white lines in the images in the second
column). However, in the presence of taurine (middle row of
images),  or  by  adding  the  gap-junctional  blocker  octanol
(lower row of images), there is virtually no spread of cell death
beyond the site of injury.
A similar result was obtained with the TUNEL assay for
apoptosis.  As  shown  in  Figure  4,  TUNEL  staining  was
observed in cells remote from the location of the scrape in
cells exposed to cyC only (upper panels). However in the
presence of taurine (middle panels) or octanol (lower panels),
TUNEL staining was observed almost exclusively in cells
near the site of the scrape (white lines).
Cell death was assayed by determining the fraction of
cells within each dish that displayed either caspase 3 activity
or TUNEL labeling. Averaged data obtained in 3 (TUNEL)
and 4 (caspase 3) separate experiments under each condition
are illustrated in Figure 5. As shown in the bar graphs, taurine
reduced cell death by more than 80% and was clearly as
effective as the gap junction blocker octanol in this regard.
Although  the  effects  of  taurine  and  related
aminosulfonates  on  gap  junctions  have  been  reported  in
numerous studies on a variety of different tissues, the results
have not been consistent and often depend on the type of
connexin expressed [43-46]. Thus it was necessary to consider
the possibility that the beneficial effects of taurine observed
under the present experimental conditions resulted from the
Figure  5.  Quantification  of  cell  death.  Percent  cell  death  was
determined  with  activated  caspase  3  immunocytochemistry  and
TUNEL assay as described in Methods. The percentage cell death
was reduced by approximately 80% in the presence of taurine or the
gap  junctional  blocker  octanol,  (p<0.001,  comparing  taurine-  or
octanol-treated group means to respective cyC-only control means;
ANOVA  with  Student-Newman-Keuls  post  hoc  testing).  The
reduction in percentage cell death in the presence of taurine was
statistically indistinguishable from that in the presence of octanol
(p>0.05). Error bars depict SEM; n=4 for caspase activity and n=3
for  the  TUNEL  assay.  “casp  3”  refers  to  activated  caspase  3
immunocytochemistry and “cyC” refers to cyctochrome C.
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1945blockage of gap-junctional conductance. However, we found
that  taurine  did  not  affect  significantly  the  junctional
conductance  between  paired  Xenopus  oocytes  expressing
Cx43.  As  shown  in  the  inset  to  Figure  6,  conductance
measurements on paired oocytes in MB (n=4) and in 40 mM
taurine  (n=4)  showed  no  significant  difference:  the  mean
conductance in MB was 4.5±0.9 µS, and in the taurine solution
it was 5.1±0.25 µS (p=0.5444 by unpaired t test; values are
mean±SEM). In addition, the junctional currents (Figure 6),
recorded over the range of ±80 mV, show that the voltage
sensitivity was not significantly affected by this concentration
of taurine. These findings are a good indication that any effects
that taurine may have on cell death are not readily attributable
to the blockage of gap junctional channels formed by Cx43.
The evidence that taurine was without effect on gap-junctional
communication mediated by Cx43, made it unnecessary to
examine its effects on cell pairs expressing Cx46. Moreover,
the study by Malfait et al. [25] suggests that Cx46 does not
Figure 6. Taurine effect on junctional conductance. Exposure to 40
mM taurine had no significant effect on the voltage sensitivity of the
junctional currents recorded over the range of ±80 mV, although
there was a slight current reduction at negative junctional voltages.
The  data  (n=4  for  each  condition)  were  fit  by  the  Boltzmann
equation: 
Gjss = { (Gjmax – Gjmin ) / ( 1 + exp [A ( Vj –Vo ) ] } +Gjmin 
where  Gjmax  (normalized  to   unity)   is  the     maximum
conductance, Gjmin is the residual conductance at large values of Vj,
and Vo is the Vj at which Gjss = (Gjmax–Gjmin)/2. The constant A
(A=nq/kT)  represents  the  voltage  sensitivity  in  terms  of  gating
charge as the equivalent number (n) of electron charges (q) moving
through the membrane, k is the Boltzmann constant, and T is the
absolute  temperature.  As  shown  in  the  inset,  taurine  had  no
significant  effect  on  the  junctional  conductance  between  paired
oocytes  expressing  this  gap-junctional  protein  (p=0.5444  by
Student’s t-test), and there were no significant differences in the
values of A for taurine treated and control oocytes in either the
positive or negative branches of the curves. These findings are a good
indication that taurine does not affect Cx43 gap junctional channels.
play a significant role in forming functional gap junctions in
RPE. That aside, we recognize that the data were obtained
from  oocytes  expressing  Cx43,  and  may  not  accurately
represent the situation in the cell lines.
DISCUSSION
Taurine (2-aminoethanesulfonic acid) is often referred to as a
“conditionally- or semi-essential amino acid” because it is not
used in protein synthesis. However, it is important to recall
that taurine is ubiquitous in nature and is the most abundant
amino acid in excitable cells and tissues throughout the body.
It comprises a large percentage of the total free amino acids
in the heart, kidney and plasma [47] and is vital for normal
development [48-51]. It is present in high concentrations in
skeletal muscle [52] and in liver, where it plays a significant
role  in  conjugation  of  bile  acids  [53-56].  Many  of  the
physiologic functions in which it has been implicated have yet
to  be  clearly  defined,  but  there  is  evidence  that  taurine
interacts  with  various  neurotransmitter  systems  [2],
participates in membrane stabilization [1,57], and is effective
in modulating numerous calcium-dependent processes [58,
59]. In addition, there is new evidence indicating that taurine
is able to inhibit apoptosis by preventing formation of the
apoptosome [60], a key element in the deleterious action of
mitochondrial-derived cytochrome C [61,62] leading to the
caspase-mediated apoptotic cascade [32,63]. Clearly there are
several avenues by which taurine can act to protect RPE cells
from cell death, and they would explain in large part both the
present experimental findings and the resistance of the outer
retina  to  metabolic  insult.  Moreover,  the  loss  of  these
properties may account for the multiple abnormalities in the
visual, cardiovascular, and reproductive systems when taurine
is  depleted  from  the  diet  of  animals  deficient  in  cysteine
sulfinic  acid  decarboxylase,  an  essential  enzyme  for  the
biosynthesis  of  taurine  from  cysteine  or  methionine  [64].
Nevertheless, it remains to be seen whether the effects of
taurine reported here result from one or more of the foregoing
mechanism or by activating some other intracellular pathway
that inhibits the cell death process.
Numerous studies have reported that cell death signals
induced by cyC and other agents can be transmitted through
the aqueous pores of gap junctions to adversely affect their
neighbors [65-69], but that this so-called “bystander effect”
[70]  can  be  suppressed  by  blocking  the  gap  junctional
channels connecting the various cell types [22,68,71]. Thus
there was the possibility that taurine exerts its beneficial effect
by  blocking  the  propagation  of  apoptosis  through  the
intercellular  channels  that  couple  RPE  cells,  a  possibility
strengthened by reports that in some cell types gap junctional
communication is inhibited by taurine [43,45]. However, as
we have shown, the gap-junctional conductance of oocytes
expressing Cx43 was not affected significantly by exposure
to moderately high concentrations of taurine.
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1946Although this study does not address directly a putative
role for taurine in diabetic retinopathy, it is noteworthy that
its effectiveness in suppressing organ lipid peroxidation [72]
and  in  reducing  insulin  resistance  [73]  has  led  to  the
suggestion that taurine may be beneficial in preventing or
ameliorating hyperglycemia-induced retinal defects [74-77].
In humans and in animal models, diabetes is consistently
associated  with  a  progressive  increase  in  a  range  of
abnormalities  affecting  the  structural  and  functional
properties of neurons and blood vessels of the inner retina
[78-80]. These findings are in contrast to the seemingly milder
effects of diabetes on the blood retinal barrier (BRB) and cells
of the outer retina. Although there are reports of reduced
amplitude  electroretinogram  potentials  generated  by  the
photoreceptors and RPE [81,82], as well as evidence of a small
reduction in the thickness of the outer nuclear layer [83], the
pathophysiological changes are neither as consistent nor as
profound as those seen in the inner retina [79,84]. This is
somewhat surprising considering the highly vascular capillary
bed (choriocapillaris) that nourishes cells of the outer retina,
the accumulation of glucose within the RPE in response to
hyperglycemia [85], and the glucose transport properties of
the photoreceptors [86] and RPE [87,88]. Clearly, the high
concentrations of taurine in the RPE and photoreceptors may
contribute to the relative sparing of the distal retina, which
occurs  despite  the  fact  that  hyperglycemia  causes  altered
expression of the tight-junctional protein occludin [89], an
increase in the lipid content of the RPE [90], and permeability
defects  in  the  RPE  [91].  Nevertheless,  the  data  on  the
beneficial effects of taurine supplementation in diabetes are
still  too  sparse  to  be  considered  significant,  and  further
biochemical and physiologic experimentation addressing this
important issue is clearly warranted.
Lastly, it has not escaped our notice that the present
results provide a possible mechanism for the protective effects
of tauroursodeoxycholic acid (TUDCA) reported by Boatright
et  al.  [3].  In  their  study,  the  authors  provide  convincing
evidence that TUDCA, a taurine containing derivative of bile
acid, protects photoreceptors from genetically mediated and
photically induced cell death. This agent, which has been
shown to prevent apoptosis in a broad spectrum of neurologic
and systemic diseases [92,93], is deconjugated by the bacterial
flora of the intestinal lumen to release taurine. Thus, it may
not be inapposite to suggest that taurine could be the active
substance underlying the therapeutic actions of TUDCA.
However, it is important to stress that in its unconjugated
form,  ursodeoxycholic  acid  (UDCA)  has  proven  to  be
efficacious in the treatment of gallstones and cholestatic liver
diseases [94]. When delivered subcutaneously, as done in the
Boatright et al. study, UDCA may be equally effective in
suppressing photoreceptor cell death.
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